Understanding perspective on Biopharma Mfg. processes in India
11/01/2021
One of our clients is looking to connect with experts in manufacturing domain who have extensive knowledge/ worked in upstream/ downstream processes and DS (drug substance)/ DP (drug product) plants of mAbs (monoclonal antibodies) and insulins. Professionals having more than 12 years experience and exposure working with global biopharma companies will be helpful.
